The Journal of Bone and Joint Surgery (American). 2008;90:55-61.
doi:10.2106/JBJS.G.01478
© 2008 The Journal of Bone and Joint Surgery, Inc.
Clinical Trial Design in Fracture-Healing Research: Meeting the Challenge
Saam Morshed, MD, MPH and
Mohit Bhandari, MD, MSc, FRCSC
Corresponding author: Mohit Bhandari, MD, MSc, FRCSC Hamilton Health
Sciences-General Hospital, 237 Barton Street East, 6 North Trauma, Hamilton,
ON L8L 2X2, Canada. E-mail address:
bhandam{at}mcmaster.ca
Disclosure: The authors did not receive any outside funding or
grants in support of their research for or preparation of this work. Neither
they nor a member of their immediate families received payments or other
benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center,
clinical practice, or other charitable or nonprofit organization with which
the authors, or a member of their immediate families, are affiliated or
associated.
The rapidly growing global burden of road-traffic accidents and fragility
fractures makes research on fracture repair a vital component of the efforts
needed to face this rising public health challenge. The focus on developing
new and innovative strategies to treat fractures is easily justifiable given
the potential human benefit from such discoveries. Randomized trials remain
the standard to which the evaluation of novel fracture-healing therapies must
continue to evolve. This article reviews randomized controlled trials in the
context of the hierarchy of evidence, special challenges to their conduct in
the setting of surgical research, and lessons learned from fracture-healing
trials published to date. Suggestions are made regarding the optimal
characteristics of fracture models and logistical consideration for ensuring
the success of future trials. The realization that surgical trials have unique
methodological and interpretative challenges has fueled a renewed vision of
the design and execution of large, definitive clinical trials with a
meaningful impact on the lives of patients.

CiteULike Connotea Del.icio.us Technorati What's this?
|